Venture Capital

Bayer-backed Metagenomi Bumps Up Series A To $75M As It Gears Up For Gene Editing Push | Fiercebiotech

by fiercebiotech.com posted 5months ago 266 views
Bayer-backed Metagenomi bumps up series A to $75M as it gears up for gene editing push badams Wed, 04/07/2021 - 09:07.: Metagenomi has added a cool $10 million extra to its January series A funding round with help from RA Capital as it also adds the VC firm’s M.D. to the board. Metagenomi got off a respectable $65 million series A at the start of the year, backed by Bayer and its gene therapy push, but now has bumped that up to $75 million and added a new board member in Andrew Levin, M.D., Ph.D.